Kbc Group Nv Simulations Plus, Inc. Transaction History

Kbc Group Nv

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$37.48 - $44.74 $262 - $313	7 Added 0.91%	775 $32,000
Q4 2023 Feb 13, 2024	SELL	$33.36 - $45.71 $15,378 - $21,072	-461 Reduced 37.51%	768 $34,000
Q3 2023 Feb 15, 2024	SELL	$40.03 - $51.51 $18,453 - $23,746	-461 Reduced 37.51%	768 $32,000
Q2 2023 Feb 15, 2024	SELL	$40.45 - $48.0 $6,188 - $7,344	-153 Reduced 11.07%	1,229 $53,000
Q2 2023 Jul 28, 2023	SELL	$40.45 - $48.0 $6,188 - $7,344	-153 Reduced 11.07%	1,229 $53,000
Q3 2022 Feb 15, 2024	BUY	$47.75 - $66.88 $29,318 - $41,064	614 Added 79.95%	1,382 $67,000
Q2 2022 Feb 14, 2024	BUY	$40.55 - $51.76 $24,897 - $31,780	614 Added 79.95%	1,382 $68,000
Q2 2022 Jul 26, 2022	BUY	$40.55 - $51.76 $56,040 - $71,532	1,382 New	1,382 $68,000

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $584M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.